Hytonen et al. [81] found, in a group of 34 patients with MS or other neuroinflammatory disease, all of whom had positive CSF oligoclonal bands, that 24 (71%) had undetectable CSF CXCL13 levels by using the Quantikine ELISA. The gene discussed is CXCL13; the disease is myeloid sarcoma.